quantisnow
FeedTopReportsPricing
⌘K
Live feed
07:19:19·715d
NEWSRelease
BRP Group Inc. (Insurance Company) logo

The Baldwin Group Announced The Offering By Its Direct Subsidiary Of $500M Aggregate Principal Amount Of Proposed Senior Secured Notes Due 2031, Subject To Market And Other Conditions

BRP· BRP Group Inc. (Insurance Company)
Finance
Original source

Companies

  • BRP
    BRP Group Inc. (Insurance Company)
    Finance

Recent analyst ratings

  • Apr 8UpdateJP Morgan$33.00
  • Dec 12UpdateRaymond James$30.00
  • Nov 8UpdateWells Fargo$24.00
  • Mar 3UpdateWilliam Blair-
  • Oct 3UpdateJP Morgan$30.00
  • Apr 18UpdateUBS$30.00

Related

  • INSIDER700d
    Bigh, Llc disposed of 125,000 units of Class B Common Stock, decreasing direct ownership by 0.94% to 13,149,090 units (SEC Form 4)
  • INSIDER700d
    Baldwin Lowry converted options into 125,000 shares, sold $4,262,018 worth of shares (125,000 units at $34.10), disposed of 125,000 units of Class B Common Stock and acquired 125,000 units of Class B Common Stock (SEC Form 4)
  • NEWS707d
    The Baldwin Group Ticker Symbol To Change To 'BWIN' On May 20, 2024
  • PR707d
    The Baldwin Group to Change Ticker Symbol to BWIN on May 20, 2024
  • SEC707d
    BRP Group Inc. (Insurance Company) filed SEC Form 8-K: Regulation FD Disclosure
  • PR707d
    The Baldwin Group Announces Successful Pricing with Improved Terms for $840 Million Term Loan B and $600 Million Revolver
  • NEWS709d
    UBS Maintains Buy on The Baldwin Insurance, Raises Price Target to $37
  • INSIDER710d
    Galbraith Daniel converted options into 155,600 shares and sold $5,436,730 worth of shares (181,481 units at $29.96), decreasing direct ownership by 80% to 6,285 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022